Evidence map›Paper›PMID 35793130›Full record

ArticleJMIR cancer2022

Public Policies and Programs for the Prevention and Control of Breast Cancer in Latin American Women: Scoping Review.

Igor Martín Ramos Herrera, María Guadalupe Lemus Flores, Antonio Reyna Sevilla, Miguel Ernesto González Castañeda, Fernando Adolfo Torres Gutiérrez, René Cristóbal Crocker Sagastume, Juan De Dios Robles Pastrana, José Luis Vázquez Castellanos

Open access · goldAbstract readScoping Review
In one paragraph

Article in JMIR cancer, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Igor Martín Ramos Herrera *Department of Public Health, University of Guadalajara, Guadalajara, Mexico.ORCID https://orcid.org/0000-0002-9325-0660
María Guadalupe Lemus Flores *Department of Public Health, University of Guadalajara, Guadalajara, Mexico.ORCID https://orcid.org/0000-0001-8898-0872
Antonio Reyna Sevilla *Department of Public Health, University of Guadalajara, Guadalajara, Mexico.ORCID https://orcid.org/0000-0001-7842-0388
Miguel Ernesto González Castañeda *Department of Public Health, University of Guadalajara, Guadalajara, Mexico.ORCID https://orcid.org/0000-0003-1047-2223
Fernando Adolfo Torres Gutiérrez *Department of Public Health, University of Guadalajara, Guadalajara, Mexico.ORCID https://orcid.org/0000-0002-3497-7894
René Cristóbal Crocker Sagastume *Department of Public Health, University of Guadalajara, Guadalajara, Mexico.ORCID https://orcid.org/0000-0001-9425-2126
Juan De Dios Robles Pastrana *Department of Geography, University of Guadalajara, Guadalajara, Mexico.ORCID https://orcid.org/0000-0001-7232-4512
José Luis Vázquez Castellanos *Department of Public Health, University of Guadalajara, Guadalajara, Mexico.ORCID https://orcid.org/0000-0002-7874-9746
Universidad de Guadalajara · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundBreast cancer has positioned itself worldwide as one of the main public health problems, especially in Latin America. In some countries, several programs for the prevention and control of breast cancer in women have been developed and implemented on a permanent basis, but there are no public reports on the policies that originated such programs.

objectiveA scoping review of scientific publications that identify the type, extent, and scope of policies and programs for the prevention and control of breast cancer in Latin American women was performed, and the main results were presented in this paper.

methodsThis scoping review was carried out according to the method by Arksey and O'Malley based on 3 fundamental questions about breast cancer prevention and control policies in Latin America: their type, extent and scope, and reference framework. The search period was from 2000 to 2019, and the search was carried out in the following databases: MEDLINE (PubMed), MEDLINE (EbscoHost), CINAHL (EbscoHost), Academic Search Complete (EbscoHost), ISI Web of Science (Science Citation Index), and Scopus in English, Spanish, and Portuguese, and Scielo, Cochrane, and MEDES-MEDicina in Spanish and Portuguese. Of the 743 studies found, 20 (2.7%) were selected, which were analyzed using descriptive statistics and qualitative content analysis.

resultsThe selected studies identified several Latin American countries that have generated policies and programs to prevent and control breast cancer in women, focusing mainly on risk communication, prevention and timely detection, effective access to health services, improvement of the screening process, and evaluation of screening programs. Evaluation criteria and greater participation of civil society in policy design and program execution are still lacking. This could undoubtedly help eliminate existing barriers to effective action.

conclusionsAlthough several Latin American countries have generated public policies and action programs for the prevention and control of breast cancer, a pending issue is the evaluation of the results to analyze the effectiveness and impact of their implementation given the magnitude of the public health problem it represents and because women and civil society play an important role in its prevention and control. INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): RR2-10.2196/12624.

Indexed as

breast cancerprevention programspublic policyscoping reviewsystematic review

Identifiers

PMID35793130
PMCPMC9301550
OpenAlexW4284697097

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.